Vanguard Group Inc Delcath Systems, Inc. Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,657,428 shares of DCTH stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,657,428
Previous 1,610,735
2.9%
Holding current value
$14.8 Million
Previous $21.9 Million
18.66%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding DCTH
# of Institutions
130Shares Held
13.1MCall Options Held
133KPut Options Held
159K-
Geode Capital Management, LLC Boston, MA688KShares$6.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT666KShares$5.95 Million0.29% of portfolio
-
State Street Corp Boston, MA621KShares$5.55 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$5.09 Million0.97% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL476KShares$4.25 Million0.31% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $76.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...